Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 111 - 115 of 121 results Formulation Development, Healthy Volunteer Trials, First-in-Human, Human ADMEBalancing time, cost and development risk when choosing the appropriate dosage form for your first-in-human Phase I trialsFormulation Development, Healthy Volunteer Trials, First-in-Human, Human ADMEBalancing time, cost and development risk when choosing the appropriate dosage form for your first-in-human Phase I trialsLearn more Solid-State Characterization, Candidate DevelopmentCandidate selection & API characterization: How do we assess the right molecules to take forward into development?Solid-State Characterization, Candidate DevelopmentCandidate selection & API characterization: How do we assess the right molecules to take forward into development?Learn more Scientific Achievements, Dr. Peter ScholesScientific Achievements in 2019Scientific Achievements, Dr. Peter ScholesScientific Achievements in 2019Learn more Site Spotlight, PhiladelphiaSpotlight on Philadelphia - Q&A with Nutan Gangrade, Managing Director of Quotient Sciences Garnet Valley and Chelsea ParkwaySite Spotlight, PhiladelphiaSpotlight on Philadelphia - Q&A with Nutan Gangrade, Managing Director of Quotient Sciences Garnet Valley and Chelsea ParkwayLearn more Translational Pharmaceutics, Modified Release, Formulation Development, Dr. Vanessa ZannDevelopment of modified release drug products: Science-led & data-driven strategiesTranslational Pharmaceutics, Modified Release, Formulation Development, Dr. Vanessa ZannDevelopment of modified release drug products: Science-led & data-driven strategiesLearn more Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Page 25 Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
